Old Web
English
Sign In
Acemap
>
authorDetail
>
Yifang Li
Yifang Li
Novartis
Medicine
Endocrinology
Internal medicine
Antagonist
TRPV1
5
Papers
15
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
LLF580, an FGF21 Analog, Reduces Triglycerides and Hepatic Fat in obese adults with modest hypertriglyceridemia.
2021
The Journal of Clinical Endocrinology and Metabolism
Daniel J. Rader
Eleftheria Maratos-Flier
Amanda Nguyen
Doug Hom
Michael Ferriere
Yifang Li
Jill Kompa
Miljen Martic
Markus Hinder
Craig T. Basson
David Yowe
John L. Diener
Allison B. Goldfine
Cllf X study team
Show All
Source
Cite
Save
Citations (1)
Topical ocular TRPV1 antagonist SAF312 demonstrated safety, low systemic exposure, and no anesthetic effect in healthy volunteers
2021
Investigative Ophthalmology & Visual Science
Yifang Li
Monish Jain
Michela Montecchi Palmer
Sameena Haque
Kalliopi Stasi
Show All
Source
Cite
Save
Citations (0)
Effects of bimagrumab, an activin receptor type II inhibitor, on pituitary neurohormonal axes
2018
Clinical Endocrinology
Tania Garito
Marjorie Zakaria
Dimitris Papanicolaou
Yifang Li
Pascale Pinot
Olivier Petricoul
Didier Laurent
Daniel Rooks
Juan Carlos Rondon
Ronenn Roubenoff
Show All
Source
Cite
Save
Citations (13)
1